Skip to content

The Effect of Aromatherapy on Post-Stroke Depression

The Effect of Aromatherapy on Post-Stroke Depression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400079491
Enrollment
Unknown
Registered
2024-01-04
Start date
2024-01-15
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-stroke depression

Interventions

control group:The control group was given unified general rehabilitation treatment and cognitive-behavioral therapy (CBT) by the hospital for 4 weeks. CBT is intervened by occupational therapists, 30
Aromatherapy intervention group 1:On the basis of routine rehabilitation treatment, the patient was given aromatherapy treatment for 4 weeks. Aromatic sniffing: In a 15 square meter treatment room, us
Aromatherapy intervention group 2:On the basis of routine rehabilitation treatment, aromatherapy intervention group 2 was given to patients with aromatherapy combined with essential oil acupoint appli

Sponsors

The Second Rehabilitation Hospital of Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? Confirmed by cranial CT or MRI and meeting the diagnostic criteria for ischemic stroke revised at the 4th Cerebrovascular Disease Conference; ? Meets the diagnostic criteria for depression in the Chinese Classification and Diagnostic Criteria for Mental Disorders (CCMD-3); ? Age range from 30 to 80 years old, regardless of gender; ? PHQ-9 score = 5 points; ? No serious cognitive impairment: MMSE = 21 points; ? Individuals without a history of depression prior to stroke; ? Normal sense of smell; ? Informed consent and voluntary participation in this study.

Exclusion criteria

Exclusion criteria: ? Unstable stroke patients ? Severe bone, joint and muscle diseases, liver, kidney and other life-threatening diseases, as well as psychiatric patients; ? Patients with severe language, visual, and hearing impairments; ? Individuals who have used aromatherapy within a month; ? Individuals with asthma and a history of respiratory diseases such as allergies to flowers, plants, and essential oils;; ? People with severe diabetes; ? Patients with scalp trauma, skin rupture, redness, swelling, inflammation, or soft tissue damage near acupoints; ? Have a history of epileptic seizures; ? Accepting other clinical trial participants.

Design outcomes

Primary

MeasureTime frame
Hospital Anxiety and Depression Scale, HADS;Patient Health Questionnaire-9, PHQ-9;electroencephalogram, EEG;

Secondary

MeasureTime frame
mini-mental state examination, MMSE;Pittsburgh sleep quality index, PSQI;stroke specific quality of life, SS-QOL;

Countries

China

Contacts

Public ContactJun Hu

The Second Rehabilitation Hospital of Shanghai

jasonhwu@126.com+86 158 0037 1522

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026